Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs Losartan in Hypertension with Hyperuricemia
NCT06718062Phase 4Completed
- Sponsor
- Hansung University
- Start
- May 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in hypertension (HTN), hyperuricemia, sponsored by Hansung University. Started May 2021; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)hyperuricemia
Beyond the preview
Go deeper on NCT06718062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06718062.